Adjuvant Interleukin-2, Interferon-alpha and 5-Fluorouracil for Patients With High Risk of Relapse After Surgical Treatment for Renal Cell Carcinoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fluorouracil; Interferon alpha; Interleukin-2
- Indications Renal cancer; Renal cell carcinoma
- Focus Therapeutic Use
- Acronyms HYDRA
- 24 Sep 2012 Biomarkers information updated
- 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
- 07 Apr 2009 Additional lead trial centres and investigators identified as reported by United Kingdom Clinical Research Network record.